XML 39 R28.htm IDEA: XBRL DOCUMENT v3.5.0.2
Business Segment Information (Tables)
 9 Months Ended
Oct. 01, 2016
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Business Segment Information
 
 
Three Months Ended
 
Nine Months Ended
 
 
October 1,

 
September 26,

 
October 1,

 
September 26,

(In millions)
 
2016

 
2015

 
2016

 
2015

 
 
 
 
 
 
 
 
 
Revenues
 
 
 
 
 
 
 
 
Life Sciences Solutions
 
$
1,231.5

 
$
1,080.4

 
$
3,642.1

 
$
3,229.6

Analytical Instruments
 
898.0

 
778.5

 
2,451.2

 
2,282.9

Specialty Diagnostics
 
798.9

 
776.9

 
2,504.8

 
2,379.2

Laboratory Products and Services
 
1,746.2

 
1,638.2

 
5,273.0

 
4,844.9

Eliminations
 
(183.7
)
 
(150.8
)
 
(550.2
)
 
(423.7
)
 
 
 
 
 
 
 
 
 
Consolidated revenues
 
4,490.9

 
4,123.2

 
13,320.9

 
12,312.9

 
 
 
 
 
 
 
 
 
Segment Income (a)
 
 
 
 
 
 
 
 
Life Sciences Solutions
 
370.1

 
332.7

 
1,069.7

 
954.9

Analytical Instruments
 
190.1

 
146.5

 
446.7

 
407.8

Specialty Diagnostics
 
214.4

 
204.9

 
682.4

 
646.2

Laboratory Products and Services
 
257.9

 
249.6

 
795.9

 
731.7

 
 
 
 
 
 
 
 
 
Subtotal reportable segments (a)
 
1,032.5

 
933.7

 
2,994.7

 
2,740.6

 
 
 
 
 
 
 
 
 
Cost of revenues charges
 
(32.4
)
 
(0.8
)
 
(60.4
)
 
(2.5
)
Selling, general and administrative charges, net
 
(62.5
)
 
(24.6
)
 
(95.2
)
 
(35.4
)
Restructuring and other costs, net
 
(54.9
)
 
(15.5
)
 
(140.9
)
 
(67.9
)
Amortization of acquisition-related intangible assets
 
(341.6
)
 
(329.9
)
 
(1,001.6
)
 
(988.8
)
 
 
 
 
 
 
 
 
 
Consolidated operating income
 
541.1

 
562.9

 
1,696.6

 
1,646.0

Other expense, net (b)
 
(113.2
)
 
(94.8
)
 
(324.6
)
 
(292.3
)
 
 
 
 
 
 
 
 
 
Income from continuing operations before income taxes
 
$
427.9

 
$
468.1

 
$
1,372.0

 
$
1,353.7

 
 
 
 
 
 
 
 
 
Depreciation
 
 
 
 
 
 
 
 
Life Sciences Solutions
 
$
34.1

 
$
38.4

 
$
108.3

 
$
106.7

Analytical Instruments
 
11.4

 
9.9

 
30.9

 
28.6

Specialty Diagnostics
 
17.3

 
18.8

 
53.5

 
54.6

Laboratory Products and Services
 
28.6

 
30.7

 
89.9

 
85.0

 
 
 
 
 
 
 
 
 
Consolidated depreciation
 
$
91.4

 
$
97.8

 
$
282.6

 
$
274.9

(a)
Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.
(b)
The company does not allocate other expense, net to its segments.
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]
Business Segment Information
 
 
Three Months Ended
 
Nine Months Ended
 
 
October 1,

 
September 26,

 
October 1,

 
September 26,

(In millions)
 
2016

 
2015

 
2016

 
2015

 
 
 
 
 
 
 
 
 
Revenues
 
 
 
 
 
 
 
 
Life Sciences Solutions
 
$
1,231.5

 
$
1,080.4

 
$
3,642.1

 
$
3,229.6

Analytical Instruments
 
898.0

 
778.5

 
2,451.2

 
2,282.9

Specialty Diagnostics
 
798.9

 
776.9

 
2,504.8

 
2,379.2

Laboratory Products and Services
 
1,746.2

 
1,638.2

 
5,273.0

 
4,844.9

Eliminations
 
(183.7
)
 
(150.8
)
 
(550.2
)
 
(423.7
)
 
 
 
 
 
 
 
 
 
Consolidated revenues
 
4,490.9

 
4,123.2

 
13,320.9

 
12,312.9

 
 
 
 
 
 
 
 
 
Segment Income (a)
 
 
 
 
 
 
 
 
Life Sciences Solutions
 
370.1

 
332.7

 
1,069.7

 
954.9

Analytical Instruments
 
190.1

 
146.5

 
446.7

 
407.8

Specialty Diagnostics
 
214.4

 
204.9

 
682.4

 
646.2

Laboratory Products and Services
 
257.9

 
249.6

 
795.9

 
731.7

 
 
 
 
 
 
 
 
 
Subtotal reportable segments (a)
 
1,032.5

 
933.7

 
2,994.7

 
2,740.6

 
 
 
 
 
 
 
 
 
Cost of revenues charges
 
(32.4
)
 
(0.8
)
 
(60.4
)
 
(2.5
)
Selling, general and administrative charges, net
 
(62.5
)
 
(24.6
)
 
(95.2
)
 
(35.4
)
Restructuring and other costs, net
 
(54.9
)
 
(15.5
)
 
(140.9
)
 
(67.9
)
Amortization of acquisition-related intangible assets
 
(341.6
)
 
(329.9
)
 
(1,001.6
)
 
(988.8
)
 
 
 
 
 
 
 
 
 
Consolidated operating income
 
541.1

 
562.9

 
1,696.6

 
1,646.0

Other expense, net (b)
 
(113.2
)
 
(94.8
)
 
(324.6
)
 
(292.3
)
 
 
 
 
 
 
 
 
 
Income from continuing operations before income taxes
 
$
427.9

 
$
468.1

 
$
1,372.0

 
$
1,353.7

 
 
 
 
 
 
 
 
 
Depreciation
 
 
 
 
 
 
 
 
Life Sciences Solutions
 
$
34.1

 
$
38.4

 
$
108.3

 
$
106.7

Analytical Instruments
 
11.4

 
9.9

 
30.9

 
28.6

Specialty Diagnostics
 
17.3

 
18.8

 
53.5

 
54.6

Laboratory Products and Services
 
28.6

 
30.7

 
89.9

 
85.0

 
 
 
 
 
 
 
 
 
Consolidated depreciation
 
$
91.4

 
$
97.8

 
$
282.6

 
$
274.9

(a)
Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.
(b)
The company does not allocate other expense, net to its segments.